Russia to test its COVID-19 vaccine 'Sputnik V' on 40,000 people next week

Russia is set to test its COVID-19 vaccine ‘Sputnik V’ on at least 40,000 people across nation starting next week and it will be monitored by a foreign research body, said backers of project on Thursday, August 20.

se are reported to be first details on magnitude of late-st trial by Russia after it anunced ‘world’s first’ COVID-19 vaccine and caused a stir on international community. Despite speculation around drug's safety, efficiency, and lack of data put forth by critics, developers of Russian vaccine are aiming to allay some of concerns.

Re - Russia Eyes Partnership With India For Producing COVID-19 Vaccine Sputnik V

In hom to world’s first satellite developed by Soviet Union, Russia named its COVID-19 vaccine candidate ‘Sputnik V’. While anuncing potential COVID-19 vaccine, Russian President Vlimir Putin mentioned that one of his two ult daughters has been iculated. authorities from nation hailed efficiency of its COVID-19 vaccine after a two-month-long small scale human trial, details of which, however, are t available to public. 

he of Russian Direct Investment Fund (RDIF) which is supporting Sputnik V, Kirill Dmitriev is reported to have said in a press briefing that a range of countries are ‘running an information war’ against Russian vaccine. He also said vaccine data would be published in an acemic journal by end of August. But, experts from around world have showcased ir scepticism against its use until all internationally-approved testing, as well as regulatory steps, have been fulfilled to prove its success. 

Re - Serum Institute Of India To Begin Trial On 1600 Volunteers For Potential COVID-19 Vaccine

Russia has received orders up to billion doses of Sputnik V

As global COVID-19 infections have surpassed 22.5 million mark with over 789,600 deaths, world has gotten more desperate to develop a suitable vaccine for vel coronavirus diseases. This has Russia covered with requests for up to a billion doses of its self-touted COVID-19 vaccine candidate.

Moreover, RDIF he also said that Russia has capacity to produce 500 million doses of Sputnik V. research involving 40,000 volunteers in Russia would be subjected to mass testing at more than 45 medical centres across nation. 

Re - Brazil Approves Human Trials For Johnson & Johnson's COVID-19 Vaccine Candidate

Re - Iran To Wait For WHO Approval On Russia's COVID-19 Vaccine Before Negotiating Deal